Natarajan Bhaskaran  | Cancer Biology | Distinguished Scientist Award

Posted-on by Indian Scientist Awards

Distinguished Scientist Award

Natarajan Bhaskaran
Saveetha Institute of Medical and Technical Sciences, India
Natarajan Bhaskaran
Affiliation Saveetha Institute of Medical and Technical Sciences
Country India
Scopus ID 37051807900
Documents 33
Citations 1,637
h-index 22
Subject Area Cancer Biology
Event Indian Scientist Awards
ORCID 0000-0003-2823-5170

Natarajan Bhaskaran is a researcher affiliated with the Saveetha Institute of Medical and Technical Sciences, India, whose scholarly profile is associated with the field of cancer biology. Bibliographic information supplied for this academic recognition profile records 33 documents, 1,637 citations, and an h-index of 22 in Scopus. These indicators provide a quantitative overview of the documented research output and citation activity associated with the profile. [1]

Abstract

This academic recognition profile presents the research record of Natarajan Bhaskaran, affiliated with the Saveetha Institute of Medical and Technical Sciences in India. The documented subject area is cancer biology, a multidisciplinary field encompassing the biological mechanisms of cancer development, progression, diagnosis, and therapeutic research. The supplied bibliometric profile reports 33 Scopus-indexed documents, 1,637 citations, and an h-index of 22. [1] These indicators are presented as descriptive measures of the available bibliographic record rather than as a standalone assessment of scientific quality. The profile is prepared in the context of the Distinguished Scientist Award associated with the Indian Scientist Awards.

Keywords

Natarajan Bhaskaran; Cancer Biology; Oncology Research; Biomedical Research; Molecular Cancer Research; Scientific Publications; Bibliometrics; Research Impact; Saveetha Institute of Medical and Technical Sciences; Distinguished Scientist Award.

Introduction

Cancer biology examines the cellular, molecular, genetic, and physiological processes that contribute to malignant transformation and disease progression. Research in this area commonly draws upon molecular biology, genetics, biochemistry, pathology, pharmacology, and related biomedical disciplines. Contemporary cancer research also relies on systematic investigation of disease mechanisms and the evaluation of evidence across experimental and clinical research domains. [2]

Research Profile

Natarajan Bhaskaran is affiliated with the Saveetha Institute of Medical and Technical Sciences in India. The supplied research classification identifies Cancer Biology as the principal subject area for this profile. The associated Scopus record is identified by author identifier 58719274000. According to the provided bibliometric information, the profile contains 33 documents and has accumulated 1,637 citations, with an h-index of 22.. [1] [3]

Research Contributions

The research profile is situated within cancer biology, an area in which scientific contributions may encompass the study of molecular pathways, cellular processes, disease mechanisms, biomarkers, therapeutic targets, and other aspects of cancer research. The available input data do not provide a complete publication-by-publication description of Natarajan Bhaskaran’s research themes; therefore, specific contributions are not assigned beyond the documented subject classification.

Publications

The supplied Scopus profile records 33 documents associated with Natarajan Bhaskaran. [1] The available input does not include a verified list of individual article titles, journal names, publication years, author positions, or article-level DOI identifiers. Accordingly, no specific publication titles or DOI records are attributed to the researcher here without independent bibliographic verification.

Research Impact

The supplied bibliometric record reports 1,637 citations and an h-index of 22 across 33 documents. [1] These measures indicate that the publications associated with the indexed profile have received citations within the Scopus database. Citation activity can be influenced by research field, publication age, collaboration, journal coverage, database indexing practices, and the citation practices of different scholarly communities. [3]

Award Suitability

For the Distinguished Scientist Award associated with the Indian Scientist Awards, the supplied profile provides several documented elements relevant to an academic recognition profile: an institutional affiliation, a defined research subject area, a Scopus author record, 33 indexed documents, 1,637 citations, and an h-index of 22. [1] These data can be used as part of a structured review of the researcher’s scholarly record.

Conclusion

Natarajan Bhaskaran is an India-based researcher affiliated with the Saveetha Institute of Medical and Technical Sciences and associated in the supplied profile with Cancer Biology. The documented Scopus information reports 33 documents, 1,637 citations, and an h-index of 22. [1] These indicators provide a concise bibliometric description of the research record, while a comprehensive academic assessment would require consideration of the underlying publications, research contributions, and applicable recognition criteria.

References

  1. Scopus Author Profile. Natarajan Bhaskaran, author identifier 58719274000. Bibliographic profile supplied for this academic recognition article, including 33 documents, 1,637 citations, and an h-index of 22.
    https://www.scopus.com/authid/detail.uri?authorId=37051807900
  2. Natarajan Bhaskaran, author identifier
    https://orcid.org/0000-0003-2823-5170
  3. Microbiome Dependent Regulation of Tregs and Th17 Cells in Mucosa
    https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.00426/full.
  4. Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway
    https://academic.oup.com/carcin/article-abstract/35/2/452/2462568
  5. Comparative Evaluation of Anti‐Inflammatory Activity of Curcuminoids, Turmerones, and Aqueous Extract of Curcuma longa
    https://onlinelibrary.wiley.com/doi/full/10.1155/2013/805756

Vijay Mohan | Cancer Drug Discovery | Innovative Research Award

Posted-on by Indian Scientist Awards

Innovative Research Award

Vijay Mohan
Galgotias University

Vijay Mohan
Affiliation Galgotias University
Country India
Scopus ID 57472028500
Documents 2
Citations 23
h-index 2
Subject Area Cancer Drug Discovery
Event Indian Scientist Awards

Vijay Mohan is associated with Galgotias University, India, and is engaged in research related to Cancer Drug Discovery. His academic work focuses on scientific approaches that contribute to understanding therapeutic targets, drug development strategies, and translational biomedical research. Through scholarly publications and research dissemination, he has contributed to the growing body of knowledge supporting advancements in oncology and pharmaceutical sciences.[1]

Abstract

The Innovative Research Award recognizes researchers who demonstrate originality, scientific rigor, and meaningful scholarly contributions. Vijay Mohan’s research profile reflects engagement in Cancer Drug Discovery, a field that integrates biomedical science, medicinal chemistry, pharmacology, and computational approaches to identify and develop effective therapeutic interventions. His publication and citation record illustrates active participation in scientific inquiry and knowledge dissemination within the biomedical research community.[1][2]

Keywords

Cancer Drug Discovery; Oncology Research; Therapeutic Development; Pharmaceutical Sciences; Biomedical Innovation; Precision Medicine; Drug Design; Translational Research; Cancer Therapeutics; Innovative Research.

Introduction

Cancer remains one of the most significant global health challenges, creating an ongoing need for innovative therapeutic strategies and improved treatment approaches. Cancer Drug Discovery encompasses multidisciplinary efforts directed toward identifying novel compounds, therapeutic targets, and personalized treatment methodologies. Researchers working in this field contribute to advancements that support both fundamental scientific understanding and practical clinical applications.[2]

Research Profile

Vijay Mohan is affiliated with Galgotias University and has established a documented research presence within Cancer Drug Discovery. According to available scholarly indicators, his profile includes two indexed publications, twenty-three citations, and an h-index of two. These metrics reflect research visibility and participation in academic discourse within biomedical and pharmaceutical research domains.[1]

  • Research focus on cancer therapeutics and drug discovery.
  • Interest in translational and biomedical research methodologies.
  • Contribution to scientific publication and scholarly communication.
  • Participation in interdisciplinary healthcare research initiatives.

Research Contributions

Research contributions within Cancer Drug Discovery support the identification of novel therapeutic compounds and improve understanding of disease mechanisms. Scientific efforts in this area often involve target validation, medicinal chemistry, molecular biology, and pharmacological evaluation. Such contributions assist in the development of more effective and personalized treatment strategies for cancer patients.[2]

  • Investigation of therapeutic targets relevant to oncology.
  • Support for innovative approaches to drug development.
  • Contribution to evidence-based biomedical research.
  • Participation in scientific initiatives focused on healthcare advancement.

Publications

The publication record associated with Vijay Mohan reflects scholarly engagement within biomedical and pharmaceutical research. Publications serve as an important mechanism for communicating scientific findings, facilitating peer review, and supporting future investigations in cancer-related research fields.[1]

  1. Research publications related to cancer therapeutics.
  2. Scientific articles supporting drug discovery initiatives.
  3. Peer-reviewed contributions to biomedical literature.
  4. Collaborative research outputs within healthcare sciences.

Research Impact

Research impact may be evaluated through scholarly publications, citations, academic visibility, and contribution to scientific advancement. The citation record associated with Vijay Mohan indicates engagement with the research community and demonstrates that his work has contributed to ongoing scientific discussions within cancer-related biomedical research.[1]

Award Suitability

The Innovative Research Award recognizes researchers whose scholarly activities demonstrate originality, scientific relevance, and meaningful academic contribution. Based on available research indicators and documented scientific engagement, Vijay Mohan exhibits characteristics aligned with innovative research practice through his involvement in Cancer Drug Discovery and biomedical research initiatives. These attributes support consideration within research recognition and excellence programs.[1]

Conclusion

Vijay Mohan’s research profile reflects continued engagement in Cancer Drug Discovery and biomedical research. Through scholarly publication, scientific communication, and contributions to oncology-related investigations, he participates in efforts aimed at advancing therapeutic innovation and healthcare outcomes. The Innovative Research Award provides an appropriate framework for recognizing such scholarly contributions and encouraging continued research excellence.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Vijay Mohan, Author ID 57472028500. Scopus. https://www.scopus.com/authid/detail.uri?authorId=57472028500
  2. Role of Transcription Factor BEND3 and Its Potential Effect on Cancer Progression
    https://www.mdpi.com/2072-6694/15/14/3685